| Trial ID: | L3419 |
| Source ID: | NCT01624116
|
| Associated Drug: |
Acarbose
|
| Title: |
Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes, Type 2
|
| Interventions: |
DRUG: Acarbose|OTHER: Diet and lifestyle|DRUG: Metformin|DRUG: Metformin/ Glimepride|DRUG: Metformin/Sitagliptin
|
| Outcome Measures: |
Primary: Change in body weight and fructosamine levels during Ramadan fasting., Change in body weight and fructosamine levels from baseline to end of Ramadan., 28 days (Average duration of Ramadan fasting) | Secondary: Change in fasting lipid profile from baseline to end of Ramadan., Change in fasting lipid profile from baseline to end of Ramadan., 28 days(average duration of Ramadan)|Change in ghrelin levels from baseline to end of Ramadan., Change in ghrelin levels from baseline to end of Ramadan., 28days (average duration of Ramadan)|Change in renal profile from baseline to end of Ramadan, Change in renal profile from baseline to end of Ramadan., 28 days(average duration of Ramadan)
|
| Sponsor/Collaborators: |
Sponsor: Services Hospital, Lahore
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
161
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-08
|
| Completion Date: |
2011-09
|
| Results First Posted: |
|
| Last Update Posted: |
2012-06-20
|
| Locations: |
Endocrinology Unit & Diabetes Management Centre, Services Hospital., Lahore, Pakistan
|
| URL: |
https://clinicaltrials.gov/show/NCT01624116
|
